Ovid Therapeutics's total assets for Q3 2025 were $63.85M, a decrease of -17.54% from the previous quarter. OVID total liabilities were $19.15M for the fiscal quarter, a -11.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.